These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 16463982)

  • 21. Rest and latent obstruction in hypertrophic cardiomyopathy: impact on exercise tolerance.
    Re F; Zachara E; Avella A; Baratta P; Di Mauro M; Penco M; Musumeci F; Tondo C
    J Cardiovasc Med (Hagerstown); 2013 May; 14(5):372-9. PubMed ID: 22728835
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Standing position alone or in combination with exercise as a stress test to provoke left ventricular outflow tract gradient in hypertrophic cardiomyopathy and other conditions.
    Dimitrow PP; Cheng TO
    Int J Cardiol; 2010 Sep; 143(3):219-22. PubMed ID: 20442001
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An overview of stress echocardiography in the study of patients with dilated or hypertrophic cardiomyopathy.
    Wu WC; Bhavsar JH; Aziz GF; Sadaniantz A
    Echocardiography; 2004 Jul; 21(5):467-75. PubMed ID: 15209731
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Intraventricular flow dynamics in hypertrophic cardiomyopathy with midventricular obstruction investigated by Doppler echocardiography].
    Nakamura T; Kitamura H; Furukawa K; Matsubara K; Katahira T; Okamuro S; Tsuji Y; Takahashi T; Kunishige H; Katsume H
    J Cardiol; 1989 Jun; 19(2):455-71. PubMed ID: 2636627
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of extent and distribution of left ventricular hypertrophy on clinical aspects and hemodynamics of patients with hypertrophic obstructive cardiomyopathy].
    Schwartzkopff B; Schwammenthal E; Lösse B; Steeg M; Strauer BE
    Z Kardiol; 1992 Jan; 81(1):15-24. PubMed ID: 1570724
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparative study of the effects of verapamil and propranolol therapy in 16 cases of obstructive hypertrophic myocardiopathy].
    Cosnay P; Fauchier JP; Lang M; Casset D; Raynaud P; Lavigne G; Itti R
    Arch Mal Coeur Vaiss; 1987 Mar; 80(3):346-55. PubMed ID: 3113357
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Percutaneous transluminal septal myocardial ablation combined with permanent dual-chamber pacing in hypertrophic obstructive cardiomyopathy: a case report].
    Ochiai N; Furukawa K; Ebizawa T; Yagi T; Akashi K; Azuma A; Nakagawa M
    J Cardiol; 2000 Nov; 36(5):331-6. PubMed ID: 11107555
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Frequency and mechanism of persistent systolic anterior motion and mitral regurgitation after septal ablation in obstructive hypertrophic cardiomyopathy.
    Delling FN; Sanborn DY; Levine RA; Picard MH; Fifer MA; Palacios IF; Lowry PA; Vlahakes GJ; Vaturi M; Hung J
    Am J Cardiol; 2007 Dec; 100(11):1691-5. PubMed ID: 18036370
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term effects of dual-chamber pacing with periodic echocardiographic evaluation of optimal atrioventricular delay in patients with hypertrophic cardiomyopathy >50 years of age.
    Topilski I; Sherez J; Keren G; Copperman I
    Am J Cardiol; 2006 Jun; 97(12):1769-75. PubMed ID: 16765132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of exercise-induced left ventricular outflow tract obstruction in symptomatic patients with non-obstructive hypertrophic cardiomyopathy.
    Shah JS; Esteban MT; Thaman R; Sharma R; Mist B; Pantazis A; Ward D; Kohli SK; Page SP; Demetrescu C; Sevdalis E; Keren A; Pellerin D; McKenna WJ; Elliott PM
    Heart; 2008 Oct; 94(10):1288-94. PubMed ID: 18032461
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pacemaker therapy of hypertrophic obstructive cardiomyopathy. PIC (Pacing in Cardiomyopathy) Study Group].
    Meisel E; Rauwolf T; Burghardt M; Kappenberger L
    Herz; 2000 Jun; 25(4):461-6. PubMed ID: 10948782
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Marked expression of plasma brain natriuretic peptide is a special feature of hypertrophic obstructive cardiomyopathy.
    Nishigaki K; Tomita M; Kagawa K; Noda T; Minatoguchi S; Oda H; Watanabe S; Morita N; Nakao K; Fujiwara H
    J Am Coll Cardiol; 1996 Nov; 28(5):1234-42. PubMed ID: 8890821
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Dual-chamber pacemakers in obstructive hypertrophic cardiomyopathy: gradient variation with stress echocardiography].
    Martínez Martínez JG; Ortuño Alcaraz D; Marín Ortuño F; Luján Martínez J; Ibáñez Criado A; Quiles Llorens JA; Sogorb Garri F
    Rev Esp Cardiol; 1998 Jan; 51(1):51-5. PubMed ID: 9580168
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Percutaneous transluminal septal myocardial ablation in the treatment of hypertrophic obstructive cardiomyopathy: short-term study].
    Veselka J; Tesar D; Urbanová T; Telekes P; Honĕk T; Neuwirth J
    Vnitr Lek; 2001 Jul; 47(7):437-43. PubMed ID: 11505713
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tissue Doppler imaging assessment of long axis left ventricular function in hypertrophic cardiomyopathy.
    Cardim N; Castela S; Cordeiro R; Longo S; Ferreira T; Pereira A; Gouveia A; Reis RP; Correia JM
    Rev Port Cardiol; 2002 Sep; 21(9):953-85. PubMed ID: 12416269
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Diastolic intraventricular gradient detected with Doppler echocardiography in hypertrophic cardiomyopathy. Report of a case].
    Branco LM; Garcia-Fernandez MA; Ibañez A; Moreno M
    Rev Port Cardiol; 1993 Feb; 12(2):169-75. PubMed ID: 8461157
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of left ventricular outflow tract area after septal reduction in obstructive hypertrophic cardiomyopathy: a real-time 3-dimensional echocardiographic study.
    Sitges M; Qin JX; Lever HM; Bauer F; Drinko JK; Agler DA; Kapadia SR; Tuzcu EM; Smedira NG; Lytle BW; Thomas JD; Shiota T
    Am Heart J; 2005 Oct; 150(4):852-8. PubMed ID: 16209993
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Percutaneous transluminal septal myocardial ablation: early results and long-term follow-up].
    Tekieli Ł; Pieniazek P; Podolec P; Tomkiewicz-Pajak L; Płazak W; Musiałek P; Leśniak-Sobelga A; Przewłocki T; Biernacka B; Zmudka K; Tracz W
    Przegl Lek; 2006; 63(8):628-32. PubMed ID: 17441371
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Mimicking of mitral stenosis by asymmetrical hypertrophic cardiomyopathy].
    Bachmann M; Gander MP
    Schweiz Med Wochenschr; 1980 Nov; 110(45):1689-92. PubMed ID: 7197047
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Echocardiographic assessment of left ventricular wall motion in hypertrophic cardiomyopathy.
    Gullace G; Knippel M; Ravizza P; Savoia MT
    G Ital Cardiol; 1982; 12(8):581-9. PubMed ID: 6892016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.